ATE323161T1 - 5' ests für sekretierte proteine die im gehirn expremiert werden - Google Patents

5' ests für sekretierte proteine die im gehirn expremiert werden

Info

Publication number
ATE323161T1
ATE323161T1 AT98936594T AT98936594T ATE323161T1 AT E323161 T1 ATE323161 T1 AT E323161T1 AT 98936594 T AT98936594 T AT 98936594T AT 98936594 T AT98936594 T AT 98936594T AT E323161 T1 ATE323161 T1 AT E323161T1
Authority
AT
Austria
Prior art keywords
ests
secreted proteins
brain
proteins expressed
sequences
Prior art date
Application number
AT98936594T
Other languages
English (en)
Inventor
Milne Edwards Jean-Bapti Dumas
Aymeric Duclert
Bruno Lacroix
Original Assignee
Serono Genetics Inst Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Inst Sa filed Critical Serono Genetics Inst Sa
Application granted granted Critical
Publication of ATE323161T1 publication Critical patent/ATE323161T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98936594T 1997-08-01 1998-07-31 5' ests für sekretierte proteine die im gehirn expremiert werden ATE323161T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/905,223 US6222029B1 (en) 1997-08-01 1997-08-01 5′ ESTs for secreted proteins expressed in brain

Publications (1)

Publication Number Publication Date
ATE323161T1 true ATE323161T1 (de) 2006-04-15

Family

ID=25420448

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936594T ATE323161T1 (de) 1997-08-01 1998-07-31 5' ests für sekretierte proteine die im gehirn expremiert werden

Country Status (8)

Country Link
US (1) US6222029B1 (de)
EP (1) EP1000150B1 (de)
JP (1) JP2001512015A (de)
AT (1) ATE323161T1 (de)
AU (1) AU8555598A (de)
CA (1) CA2296667A1 (de)
DE (1) DE69834190T2 (de)
WO (1) WO1999006552A2 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261562B1 (en) 1997-02-25 2001-07-17 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
PL196260B1 (pl) 1997-02-25 2007-12-31 Corixa Corp Polipeptyd, cząsteczka DNA, komórka gospodarza, białko fuzyjne, kompozycje farmaceutyczne i szczepionki do leczenia raka prostaty
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6329505B1 (en) 1997-02-25 2001-12-11 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
US6800746B2 (en) 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6630305B1 (en) 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6620922B1 (en) 1997-02-25 2003-09-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7202342B1 (en) 1999-11-12 2007-04-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6465611B1 (en) 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6894146B1 (en) 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6395278B1 (en) 1997-02-25 2002-05-28 Corixa Corporation Prostate specific fusion protein compositions
US7033827B2 (en) 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6818751B1 (en) 1997-08-01 2004-11-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6613872B1 (en) 1997-02-25 2003-09-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
US7119190B2 (en) 1997-04-14 2006-10-10 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human G protein-coupled receptors
US20030068623A1 (en) * 1997-06-16 2003-04-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2248971A1 (en) * 1997-10-31 1999-04-30 Kyowa Hakko Kogyo Co., Ltd. .beta.1, 3-n-acetylglucosaminyltransferase, dna encoding it and its use
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
US7045612B2 (en) 1998-01-16 2006-05-16 Mcgill University Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, and cancer
US6232110B1 (en) * 1998-04-17 2001-05-15 Emory Univeristy Coding sequence for protein phosphatase methylesterase, recombinant DNA molecules and methods
AU2006202355B2 (en) * 1998-05-01 2009-08-20 Glaxosmithkline Biologicals Sa Neisseria meningitidis antigens and compositions
US6096526A (en) * 1998-05-20 2000-08-01 Incyte Pharmaceuticals, Inc. Human nucleic acid methylases
US6825328B1 (en) * 1998-07-20 2004-11-30 Stephen W. Scherer Lafora's disease gene
JP2002522016A (ja) * 1998-07-22 2002-07-23 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 神経内分泌特異的タンパク質に類似したタンパク質、およびそれをコードするｃＤＮＡ
EP1105477A1 (de) 1998-08-20 2001-06-13 Regeneron Pharmaceuticals, Inc. Dcr5: ein protein, das an bmp bindet, und verwendungen davon
US20030009013A1 (en) * 1998-12-30 2003-01-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2003521239A (ja) * 1999-04-09 2003-07-15 キュラジェン コーポレイション 新規ヒトタンパク質およびそれらをコードするポリヌクレオチド
JP2001269184A (ja) * 1999-06-28 2001-10-02 Takeda Chem Ind Ltd 新規タンパク質およびそのｄｎａ
US6682917B1 (en) * 1999-06-28 2004-01-27 Takeda Chemical Industries, Ltd Protein having a ribonucleotide Reductase activity and a DNA thereof
US6596527B1 (en) * 1999-07-31 2003-07-22 Board Of Regents, The University Of Texas Sytem Composition and methods relating to SENP 1- a sentrin-specific protease
ES2189560B1 (es) 1999-10-01 2005-01-01 Consejo Superior De Investigaciones Cientificas Dna polimerasa k, nuevo marcador tumoral.
CA2390547A1 (en) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human g protein-coupled receptors
WO2001088119A1 (fr) * 2000-04-28 2001-11-22 Takeda Chemical Industries, Ltd. Nouvelle proteine recepteur couplee a une proteine g et adn associe
JP2004523201A (ja) * 2000-05-16 2004-08-05 ザ チルドレンズ マーシー ホスピタル シングルコピーゲノムのハイブリダイゼーションプローブおよびその作製方法
US6828097B1 (en) * 2000-05-16 2004-12-07 The Childrens Mercy Hospital Single copy genomic hybridization probes and method of generating same
CN100553636C (zh) 2000-08-04 2009-10-28 Dmi生物科学公司 二酮基哌嗪和包含它们的组合物的使用方法
US7442765B2 (en) * 2000-08-24 2008-10-28 Genentech, Inc. Secreted transmembrane polypeptides and nucleic acids encoding the same
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
WO2002083921A2 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US6902902B2 (en) 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
WO2004030522A2 (en) * 2002-10-02 2004-04-15 Dmi Biosciences, Inc. Diagnosis and monitoring of diseases
EP2517718B1 (de) 2003-05-15 2016-03-02 Ampio Pharmaceuticals, Inc. Behandlung von T-Zell-vermittelten Krankheiten
EP1636258A2 (de) * 2003-06-10 2006-03-22 Xantos Biomedicine AG Angiogenischer faktor und inhibitoren davon
KR20070036089A (ko) * 2004-07-02 2007-04-02 제넨테크, 인크. 비호지킨 림프종의 치료 방법 및 치료 조성물
WO2008097467A1 (en) * 2007-02-02 2008-08-14 University Of Vermont And State Agricultural College Anti-methylation-controlled j protein antibodies and uses thereof
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
EP2613786A4 (de) 2010-09-07 2013-10-23 Dmi Acquisition Corp Behandlung von erkrankungen
MY172699A (en) 2011-10-10 2019-12-10 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
EA028343B1 (ru) 2011-10-10 2017-11-30 Ампио Фармасьютикалз, Инк. Лечение дегенеративного заболевания сустава
EP2771007B1 (de) 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Behandlung von rhinitis
WO2014011742A1 (en) 2012-07-11 2014-01-16 University Of Vermont And State Agricultural College Method and composition for metabolic regulation
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
RU2736513C2 (ru) 2014-08-18 2020-11-17 Ампио Фармасьютикалз, Инк. Лечение патологических состояний суставов
AU2016220024B2 (en) 2015-02-18 2020-10-15 University Of Vermont And State Agricultural College MCJ agonists and uses therefor
EP3310375A4 (de) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Verwendung von niedermolekularen fraktionen von humanem serumalbumin bei der behandlung von erkrankungen
WO2017011356A2 (en) 2015-07-10 2017-01-19 University Of Vermont And State Agricultural College Methods and compositions to treat drug-induced diseases and conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0832981A1 (de) 1987-02-17 1998-04-01 Pharming B.V. DNA-Sequenzen die Proteine zwecks effizienter Abscheidung zur Milchdrüse leiten
JP3337748B2 (ja) 1992-09-25 2002-10-21 財団法人神奈川科学技術アカデミー 完全長ｃＤＮＡの合成方法、その中間体の製造方法及び完全長ｃＤＮＡを含む組換えベクターの製造方法
FR2733762B1 (fr) 1995-05-02 1997-08-01 Genset Sa Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
US5707829A (en) 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby

Also Published As

Publication number Publication date
CA2296667A1 (en) 1999-02-11
DE69834190D1 (de) 2006-05-24
JP2001512015A (ja) 2001-08-21
WO1999006552A2 (en) 1999-02-11
WO1999006552B1 (en) 1999-06-03
EP1000150A2 (de) 2000-05-17
WO1999006552A3 (en) 1999-04-22
US6222029B1 (en) 2001-04-24
AU8555598A (en) 1999-02-22
DE69834190T2 (de) 2007-01-11
EP1000150B1 (de) 2006-04-12

Similar Documents

Publication Publication Date Title
DE69834190D1 (de) 5' ests für sekretierte proteine die im gehirn expremiert werden
ATE338117T1 (de) 5' ests für proteine, die nicht gewebespezifisch sind
DE69842099D1 (de) 5' ESTs für sekretierte Proteine, die in verschiedenen Geweben exprimiert werden
ATE361933T1 (de) 5' ests für sekretierte proteine aus gehirngeweben
WO1999006550A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE
WO1999053051A3 (en) 5' ests and encoded human proteins
EP1033401A3 (de) Exprimierte Sequenzmarker und kodierte menschliche Proteine
WO1999006554A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES
ATE328078T1 (de) 5' ests für sekretierte proteine die in verschiedenen geweben expremiert werden
WO1999006439A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM
DE69841110D1 (de) Verlängerte cdns, die für sekretierte proteine kodieren
WO1999025825A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
WO1999040189A3 (en) Cdnas encoding secreted proteins
DE69633664D1 (de) Genetische marker für brust und eierstockkrebs
WO1999054461A3 (de) Menschliche nukleinsäuresequenzen aus endometriumtumorgewebe
IL95806A0 (en) The human c3b/c4b receptor(cr1)
DE69840387D1 (de) Nik proteine, nukleinsäure sowie verfahren
WO1999054447A3 (de) Menschliche nukleinsäuresequenzen aus blasentumorgewebe
DE69616288D1 (de) Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6
黄威权 et al. Immunohistochemical and in situ hybridized histochemical studies of SP and SPmRNA in early human placenta
EP1903111A3 (de) Erweiterte cDNA für sekretierte Proteine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties